Effects of oral and transdermal low-dose estrogen therapy on echocardiographic parameters of cardiac function

Fertility and Sterility

Volumn 80, Issue 3, 2003, Pages 546-553

  Vogelvang, Tatjana E ^a   Van Der Mooren, Marius J ^a   Kamp, Otto ^a   Mijatovic, Velja ^a   Visser, Cees A ^a   Kenemans, Peter ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac function; Echocardiography; Low dose hormone replacement therapy; Postmenopausal; Transdermal

Indexed keywords

ESTROGEN; GESTODENE; PLACEBO;

ACCELERATION; ADULT; AGED; ARTICLE; CARDIOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; FLOW RATE; GYNECOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE EJECTION TIME; HEART VENTRICLE WALL; HUMAN; HYSTERECTOMY; M MODE ECHOCARDIOGRAPHY; MULTICENTER STUDY; NORMAL HUMAN; OUTPATIENT DEPARTMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYSTOLE; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0042336013     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00754-4     Document Type: Article

References (27)

1. Wenger N.K., Speroff L., Packard B. Cardiovascular health and disease in women. N Engl J Med. 329:1993;247-256.
2. Grodstein F., Stampfer M.J., Manson J.E., Colditz G.A., Willett W.C., Rosner B., et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 335:1996;453-461.
3. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613.
4. Samsioe G., Neves-e-Castro M., Pines A., Doeren M., Utian W.H., Jaffe R.B., et al. Critical comments. Maturitas. 40:2001;5-15.
5. Grady D., Herrington D., Bittner V., Blumenthal R., Davidson M., Hlatky M., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy Heart and Estrogen/Progestin Replacement Study follow-up (HERS II) . JAMA. 288:2002;49-57.
6. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333.
7. Mijatovic V., Van der Mooren M.J., Stehouwer C.D.A., Netelenbos J.C., Kenemans P. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection. Gynecol Endocrinol. 13:1999;130-144.
8. Lang U., Baker R.S., Clark K.E. Estrogen-induced increases in coronary blood flow are antagonized by inhibitors of nitric oxide synthesis. Eur J Obstet Gynecol Reprod Biol. 74:1997;229-235.
9. Pines A., Fisman E.Z., Levo Y., Averbuch M., Lidor A., Drory Y., et al. The effects of hormone replacement therapy in normal postmenopausal women measurements of Doppler-derived parameters of aortic flow . Am J Obstet Gynecol. 164:1991;806-812.
10. Pines A., Fisman E.Z., Ayalon D., Drory Y., Averbuch M., Levo Y. Long-term effects of hormone replacement therapy on Doppler-derived parameters of aortic flow in postmenopausal women. Chest. 102:1992;1496-1498.
11. Voutilainen S., Hippelainen M., Hulkko S., Karppinen K., Ventila M., Kupari M. Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women. Am J Cardiol. 71:1993;614-617.
12. Taskin O., Gokdeniz R., Muderrisoglu H., Korkmaz M.E., Uryan I., Atmaca R., et al. The effects of hormone replacement therapy on echocardiographic basic cardiac functions in postmenopausal women. Hum Reprod. 13:1998;2399-2401.
13. Fak A.S., Erenus M., Tezcan H., Caymaz O., Oktay S., Oktay A. Effects of a single dose of oral estrogen on left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunction. Fertil Steril. 73:2000;66-71.
14. Kamali P., Müller T., Lang U., Clapp J. Cardiovascular responses of perimenopausal women to hormonal replacement therapy. Am J Obstet Gynecol. 182:2000;17-22.
15. Pines A., Fisman E.Z., Averbuch M., Eckstein N., Drory Y., Bakshi R., et al. Left ventricular function during a short-term transdermal estradiol therapy in postmenopausal women a double-blind placebo-controlled echocardiographic study . Eur Menopause J. 3:1996;53-59.
16. Snabes M.C., Payne J.P., Kopelen H.A., Dunn J.K., Young R.L., Zoghbi W.A. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women a randomized, double-blind, placebo-controlled, crossover trial . Obstet Gynecol. 89:1997;332-339.
17. Lee M., Giardina E.G., Homma S., DiTullio M.R., Sciacca R.R. Lack of effect of estrogen on rest and treadmill exercise in postmenopausal women without known cardiac disease. Am J Cardiol. 80:1997;793-797.
18. Kessel H., Kamp O., Kenemans P., Mijatovic V., Van Baal W.M., Visser C.A., et al. Effects of 15 months 17β-estradiol/dydrogesterone on systolic cardiac function using quantitative and Doppler echocardiography in healthy postmenopausal women. Am J Obstet Gynecol. 184:2001;910-916.
19. Vogelvang T.E., Mijatovic V., Kamp O., Netelenbos J.C., Neele S.J.M., Pines A., et al. Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women two randomized, placebo-controlled, 2-year studies . Am J Obstet Gynecol. 186:2002;729-736.
20. Light K., Hinderliter A., West S., Grewen K., Steege J., Sherwood A., et al. Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women. J Hypertens. 19:2001;269-278.
21. Grodstein F., Manson J.E., Colditz G.A., Willett W.C., Speizer F.E., Stampfer M.J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 133:2000;933-941.
22. Mijatovic V., Kenemans P., Jakobs C., Van Baal W.M., Peters-Muller E.R.A., Van der Mooren M.J. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol. 91:1998;432-436.
23. Davidson M.H., Maki K.C., Marx P., Maki A.C., Cyrowski M.S., Nanavati N., et al. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med. 160:2000;3315-3325.
24. Lobo R.A., Bush T., Carr B.R., Pickar J.H. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril. 76:2001;13-24.
25. Modena M.G., Muia N. Jr, Aveta P., Molinari R., Rossi R. Effects of transdermal 17beta-estradiol on left ventricular anatomy and performance in hypertensive women. Hypertension. 34:1999;1041-1046.
26. Pearlman A.S., Gardin J.M., Martin R.P., Parisi A.F., Popp R.L., Quinones M.A., et al. Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography Committee for Physician Training in Echocardiography. Am J Cardiol. 60:1987;158-163.
27. Godsland I.F. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations analysis of studies published from 1974-2000 . Fertil Steril. 75:2001;898-915.